High-throughput Prediction of Compound Tissue Distribution

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1R43GM078881-01
Agency Tracking Number: GM078881
Amount: $99,909.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: PHS2006-2
Solicitation Year: 2006
Award Year: 2006
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 (302) 654-4492
Business Contact
Phone: (302) 654-4492
Email: reppy@absbio.com
Research Institution
DESCRIPTION (provided by applicant): The aim of the proposed research is to develop tools for the prediction of the distribution of drug compounds in the human body. There is currently no experimental high throughput screening (HTS) method for determining compound tissue distribution. A drug compound's propensity to be taken up by different tissues and organs affects whether it will reach its action target, whether it will cause undesirable side-effects and hence, whether it will be clinically viable. A high-throughput in vitro method for predicting distribution of drug compounds in the human body would be an important addition to pre-clinical screening of new chemical entities (NCEs). This proposal is for the development of a novel method for the prediction for NCEs of the overall volume of distribution (Vss) and the relative distribution among tissues, consisting of a unique combination of simple fluorescent liposome-based in vitro screening assays and state- of-the-art computational models. The proposed method will be used in the pre-clinical evaluation of drug candidates to provide a standard and cost effective way to predict the overall distribution and specific tissue uptake of drug candidates. Prediction of what will happen to a drug compound in the body is an important part of the drug development process. We are proposing to develop new tools for predicting where in the human body drug compounds will be distributed; this information will allow drug developers to determine early in the development cycle whether their drug candidates will reach their target and aid in their analysis of overall compound pharmacokinetics. Implementation of these tools will reduce the cost of drug development and accelerate the drug discovery process.

* Information listed above is at the time of submission. *

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government